Key Takeaway: AUTOLUS THERAPEUTICS PLC
(formerly AUTOLUS THERAPEUTICS LIMITED)
in US Dollars, unless otherwise stated)
March 31, 2018 TOTAL ASSETS $ Liabilities Equity Share capital ( 0.00001 par value, one hundred thousand shares, issued and outstanding) 1 Additional paid
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+23%
120-day peak, hindsight
Typical move
11.6%
average across 2 past catalysts
Cash runway
~24 mo
Low dilution risk
Lead asset
Obecabtagene autoleucel
Phase 2 · Lupus Nephritis
Full Press Release Details
AUTOLUS THERAPEUTICS PLC
(formerly AUTOLUS THERAPEUTICS LIMITED)
in US Dollars, unless otherwise stated)
March 31, 2018
TOTAL ASSETS
$
Liabilities
Equity
Share capital ( 0.00001 par value, one hundred thousand shares, issued and outstanding)